Quality & compliance
Good Distribution Practice principles applied to every product, document and shipment.
Our quality framework
Quality is a process, not a promise
Pharmaceutical products are only as good as the supply chain that delivers them. Our quality framework is built on the principles of Good Distribution Practice (GDP) as described by the World Health Organization and the European Union, adapted to the realities of cross-border trade.
From the qualification of a new supplier to the handover of temperature records at delivery, every step is documented, owned and reviewed.
Six pillars of our quality system
Supplier qualification
GMP certificates, regulatory history and audit reports reviewed before the first purchase; periodic re-qualification thereafter.
Customer qualification
We supply only licensed importers, wholesalers and healthcare institutions, and verify licences before shipment.
Documentation & traceability
Batch-level documentation and records linking every unit from manufacturer to customer.
Storage & transport control
Temperature-mapped storage and validated transport packaging with continuous monitoring.
Deviation & recall management
Written procedures for deviations, complaints, returns, falsified-product suspicion and recalls.
Training & improvement
Staff trained in GDP principles; processes reviewed and improved through regular self-inspection.
Cold chain
Temperature integrity from origin to destination
Temperature-sensitive products – vaccines, biologics, insulin, certain antibiotics – require unbroken cold-chain control. We plan every cold-chain shipment individually, selecting packaging, route and partners to match the product’s requirements and transit time.
- Validated passive and active packaging solutions
- Calibrated data loggers with reports provided to the customer
- Pre-booked pharma lanes with temperature-controlled handling at transfer points
- Excursion assessment procedure with manufacturer involvement
Standards and references we work to
Our processes are aligned with internationally recognised guidelines for the distribution of medicinal products and medical devices.
Our commitment against falsified medicines
Falsified and substandard medicines are a serious threat to patients in many of the markets we serve. We take a firm position: we purchase only from manufacturers and authorised distributors with verifiable credentials, we maintain complete chain-of-custody records and we cooperate fully with regulators and manufacturers in any investigation.
- No purchases from unverified or grey-market sources
- Verification of serialisation and tamper-evident features where applicable
- Immediate quarantine and reporting procedure for suspected falsified products
- Transparency with customers about product origin
Let’s discuss your supply or regulatory project
Tell us which products, markets and volumes you have in mind. Our team replies within one business day with a clear next step.